SP-8356, EMODIN, AND IT603 ENHANCE BEIGE ADIPOCYTE ACTIVITY AND ALLEVIATE OBESITY AND DIABETES VIA UNCOUPLING PROTEIN 1 (UCP1)-INDEPENDENT MECHANISM
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Jan 16, 2025
app pub date -
Jul 3, 2024
filing date -
Jul 3, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The subject invention pertains to compositions and methods for the activation of beige adipocytes. The subject invention further pertains to methods of treating obesity, diabetes, and metabolic diseases. In certain embodiments, the subject composition comprises SP-8356 or a derivative thereof, emodin or a derivative thereof, IT603 or a derivative thereof, or any combination thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully